Asia Pacific Pharmaceutics And Drug Delivery Congress

April 11-12, 2022 | UK

Asia Pacific Pharmaceutic
Conference Series LLC Ltd is going to host “Asia Pacific Pharmaceutics & Drug Delivery Congress” which is going to be held during , April 11-12,2022 in Conference with the theme “Recent advances and further challenges in Pharmaceutics”. We are welcoming all the Speakers and Delegates from every corner of the World to join us at Asia Pacific Pharmaceutics & Drug Delivery Congress (Asia Pharmaceutics 2022).

Spotlight

The FDA issued final guidance on the use of patient-reported outcome measures in clinical trials and how sponsors can use these tools to support labeling claims. Since then, patient-centric trial activity has been fairly stable and consistent.


OTHER PAST CONFERENCES

Pharmaceutical Regulatory Affairs and IPR

April 13-14, 2022 | USA

With the coordination of renowned speakers of Regulatory Affairs 2018 Conference series LLC Ltd is privileged to announce "10th International Conference on Pharmaceutical Regulatory Affairs and IPR" which is slated on April 13-14, 2022 Montreal, Canada.

Pharmaceutical Sciences and Innovations in Pharma Industry

May 23-24, 2022 | Austria

The most anticipated Pharma event in the world and you're invited to attend 22nd World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry Scheduled during May 23-24, 2022 Vienna, Austria which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.

Biomarkers & Precision Oncology World Congress

June 20-22, 2022 | USA

Cambridge Healthtech Institute’s Seventeenth Annual Biomarkers & Precision Oncology World Congress is the longest-running event dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines.

INTERNATIONAL CONFERENCE ON MEDICAL, BIOLOGICAL AND PHARMACEUTICAL SCIENCES

June 6-7, 2022 | Mauritius

Welcome to the official website of from World Academics. will be held in Port Louis, Mauritius during 6th June-7th June 2022. .

Spotlight

The FDA issued final guidance on the use of patient-reported outcome measures in clinical trials and how sponsors can use these tools to support labeling claims. Since then, patient-centric trial activity has been fairly stable and consistent.

resources